Janssen Biotech, Inc.May 18, 2026

FDA 483 - Janssen Biotech, Inc. - May 18, 2026

FDA 483 for Janssen Biotech, Inc. on May 18, 2026. Product: biologics. Access full analysis and detailed observations.

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 483 for Janssen Biotech, Inc. on May 18, 2026. Product: biologics. Access full analysis and detailed observations.

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Janssen Biotech, Inc.

Inspection Date

May 18, 2026

Product Type

biologics

Office

FDA District Office — Philadelphia, Pennsylvania

People

Anita R. Michael (Investigator)

ID: 49d46fef-c43c-4edf-92a6-85e4dd41c6cb

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox